Stay updated with breaking news from Yi ba. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Innovent Releases Phase 1 Results of Pemigatinib in Chinese Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021 News provided by Share this article Share this article SAN FRANCISCO and SUZHOU, China, June 6, 2021 /PRNewswire/ Innovent Biologics, Inc. ( Innovent , HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced that the results of the Phase 1 study in Chinese patients with advanced solid tumors were released today at the American Society for Clinical Oncology (ASCO) Annual Meeting 2021. This is a Phase 1 study to evaluate the pharmacokinetic (PK), pharmacodynamic (PD) and safety of pemigatinib in Chinese patients (pts) with advanced malignancy. Moreover, potential efficacy of pemigatinib was explored in a broad spectrum of fibroblast growth factor receptor (FGFR) alteration in variety of ....
Innovent Will Publish Multiple Clinical Data at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
DIC : Guy Marius Sagna arrêté - Xalima.com xalimasn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from xalimasn.com Daily Mail and Mail on Sunday newspapers.
Affaire Diary Sow : la piste de la fugue confirmée par les enquêteurs français seneweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seneweb.com Daily Mail and Mail on Sunday newspapers.